NEWS!!!!!!
Cytogenix, Inc. has agreed, in principle, to purchase GE Healthcare for $3.2 Billion dollars. According to company CEO Malcolm Skolnick, their projections for synDNA sales and their current pre-clinical studies in which they have potentially cured 17 of the 20 deadliest diseases known to mankind, CYGX should have enough cash on hand in 5 years to pay for the acquisition of this enormous division of giant conglomerate General Electric. Of course, Dr. Skolnick admitted that CYGX would first have to borrow $1 million dollars so that the company could file its first IND for an actual product to treat genital herpes topically. When questioned about this proposed plan, Dr. Skolnick added that once the acquisition of GE Healthcare was complete, CYGX would turn its attention toward buying AMGEN, GENENTECH and the BROOKLYN BRIDGE...........
